Soni Manmeet Singh 4
4 · Summit Therapeutics Inc. · Filed Oct 16, 2023
Insider Transaction Report
Form 4
Soni Manmeet Singh
DirectorCOO and CFO
Transactions
- Award
Stock Option (right to buy)
2023-10-13+14,000,000→ 14,000,000 totalExercise: $1.68Exp: 2033-10-13→ Common Stock (14,000,000 underlying) - Purchase
Common Stock
2023-10-13$1.68/sh+2,976,190$4,999,999→ 2,976,190 total
Footnotes (3)
- [F1]The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68.
- [F2]The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 14,000,000 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
- [F3]Not applicable.